Madrigal Pharmaceuticals ... (MDGL)
undefined
undefined%
At close: undefined
304.50
0.67%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue - - - - - - - - - - - 147.00K 7.58M 14.80M 144.25M 2.62M 743.00K - - 173.00K 1.30M - -
Cost of Revenue 527.00K 467.00K 405.00K 471.00K 112.00K 96.00K 77.00K 156.00 - - - - - - - - - - - - - - -
Gross Profit -527.00K -467.00K -405.00K -471.00K -112.00K -96.00K -77.00K -156 - - - 147.00K 7.58M 14.80M 144.25M 2.62M 743.00K - - 173.00K 1.30M - -
Operating Income -380.50M -293.57M -242.48M -206.67M -94.97M -40.68M -32.06M -25.22M -67.61M -83.95M -87.56M -60.94M -45.43M -36.90M 79.30M -93.71M -66.22M -59.15M -71.18M -46.93M -28.29M -36.26M -401.00K
Interest Income 19.58M 2.19M 363.00K 4.33M 11.02M 7.67M 558.00K 48.30K - - - - - - 96.00K 1.58M - - - - - - -
Pretax Income -373.63M -295.35M -241.85M -202.24M -83.95M -32.81M -31.15M -26.39M -68.67M -86.16M -90.19M -62.79M -47.38M -37.47M 79.09M -92.62M -122.08M -59.13M -68.86M -47.52M -27.88M -54.35M -
Net Income -373.63M -299.31M -241.08M -197.44M -72.81M -32.81M -31.15M -26.39M -68.67M -86.16M -90.19M -62.79M -47.38M -37.47M 79.09M -92.62M -63.49M -57.27M -68.86M -45.93M -27.88M -36.15M -381.00K
Selling & General & Admin 108.15M 48.13M 37.32M 21.86M 22.65M 15.29M 7.67M 9.29M 13.39M 15.75M 15.70M 11.68M 11.55M 11.45M 12.65M 14.74M 14.93M 8.65M 11.28M 7.38M 5.26M - 124.00K
Research & Development 272.35M 245.44M 205.16M 184.81M 72.32M 25.39M 24.39M 15.93M 54.22M 68.20M 71.86M 49.41M 41.46M 40.25M 51.05M 81.58M 52.02M 50.50M 59.90M 38.14M 24.34M 7.29M 277.00K
Other Expenses - - 273.00K 100.00K - 200.00K 350.00K - - - - - - - 1.24M - - - - - - - -
Operating Expenses 380.50M 293.57M 242.48M 206.67M 94.97M 40.68M 32.06M 25.22M 67.61M 83.95M 87.56M 61.09M 53.02M 51.70M 63.70M 96.32M 66.96M 59.15M 71.18M 45.52M 29.60M 7.29M 401.00K
Interest Expense 12.71M 3.96M - - 11.02M 7.67M 558.00K 1.16M 1.06M 2.21M 2.63M 1.85M 1.95M 569.00K 312.00K 489.00K - - - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 380.50M 293.57M 242.48M 206.67M 94.97M 40.68M 32.06M 25.22M 67.61M 83.95M 87.56M 61.09M 53.02M 51.70M 63.70M 96.32M 66.96M 59.15M 71.18M 45.52M 29.60M 7.29M 401.00K
Income Tax - 3.96M -768.00K -4.80M -11.14M 7.87M -635.00K -373 - - - - - - 1.45M - -2.72M -1.88M -2.32M 588.00K -416.00K -18.20M 381.00K
Shares Outstanding (Basic) 18.69M 17.14M 16.54M 15.45M 15.39M 14.80M 12.24M 5.20M 171.01K 2.81M 2.03M 1.70M 1.35M 1.15M 968.21K 963.86K 927.59K 636.14K 635.80K 534.39K 624.37K 344.04K 83.73K
Shares Outstanding (Diluted) 18.69M 17.14M 16.54M 15.45M 15.39M 14.80M 12.24M 5.20M 171.01K 2.81M 2.03M 1.70M 1.35M 1.15M 974.81K 963.86K 927.59K 636.14K 635.80K 534.39K 624.37K 344.04K 83.73K
EPS (Basic) -19.99 -17.47 -14.58 -12.78 -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 81.55 -96.09 -68.45 -90.03 -108.31 -85.96 -44.65 -105.09 -4.55
EPS (Diluted) -19.99 -17.47 -14.58 -12.78 -4.73 -2.22 -2.54 -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 81.20 -96.09 -68.45 -90.03 -108.31 -85.96 -44.65 -105.09 -4.55
EBITDA -379.97M -293.10M -242.08M -206.20M -94.86M -40.59M -31.98M -22.52M -3.23M -83.28M -87.04M -60.20M -43.97M -34.97M 81.86M -90.99M -62.87M -53.62M -71.04M -43.80M -27.29M 10.80M -401.00K
Depreciation & Amortization 527.00K 467.00K 405.00K 471.00K 112.00K 96.00K 77.00K 156.00 662.00K 673.00K 516.00K 738.00K 1.46M 1.93M 2.46M 2.72M 3.35M 3.65M 2.46M 1.55M 1.01M 47.06M -